http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-839271-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_366a19489c5e7eec53d9d57c5ca5657b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-08
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C67-347
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C61-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-753
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C67-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-608
filingDate 1958-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1960-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-839271-A
titleOfInvention 2-(hydroxyalkyl)-bicyclo[2,2,1]-heptene and -heptane derivatives and their preparation
abstract The invention comprises compounds of the general formula <FORM:0839271/IV (b)/1> (wherein R represents a straight or branched chain alkyl radical of 1-4 carbon atoms, X represents a hydrogen atom or a non-toxic salt-forming radical, and R1 represents -CH = CH-or -CH2-CH2-), and the preparation thereof by: (A) reacting 2-formyl-bicyclo-[2,2,1]-hept-5-ene with a Grignard compound R.Mg.Halogen, or (B) converting a 2-halobicyclo-[2,2,1]-hept-5-ene into its Grignard compound and reacting this with an aldehyde R-CHO, or (c) reducing a compound of the general formula <FORM:0839271/IV (b)/2> with aluminium isopropylate in isopropyl alcohol, and in each case, if desired, catalytically hydrogenating the product to convert -CH= CH- to -CH2-CH2-, or (D) reducing the starting materials of (A), (B) or (C) to the corresponding ring-saturated compounds and subjecting these to processes (A), (B) or (C); and in all cases reacting the resulting carbinols with succinic anhydride to form their succinic acid hemi-esters and, if desired, dissolving these in an aqueous solution of a salt-forming base. The products are useful therapeutically on account of the cholalogue activity.
priorityDate 1957-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474094
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491804
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409773006
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7922
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID95117
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359268
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520590

Total number of triples: 30.